Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Scientific Reports|May 20, 2025
Value of PET radiomic features for diagnosis and reccurence prediction of newly diagnosed oral squamous cell carcinomaElisabeth Pfaehler, Andreas Schindele, Alexander Dierks, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2026
Mass Dose Effects in FAP-Directed Imaging: Influence of Administered Dose of [<sup>68</sup>Ga]Ga-LNTH-1363S on Image QualityJohanna S Enke, Jan Baessler, Gitasha Chand, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2024
[<sup>68</sup>Ga]Ga-RAYZ-8009: A Glypican-3-Targeted Diagnostic Radiopharmaceutical for Hepatocellular Carcinoma Molecular Imaging-A First-in-Human Case SeriesAlex J Poot, Constantin Lapa, Wolfgang A Weber, et al.Molecular Imaging and Biology|May 4, 2026
Diagnostic Performance of Somatostatin Receptor-directed PET/CT for Tumor-induced OsteomalaciaMarieke Heinrich, Aleksander Kosmala, Alexander Dierks, et al.Clinical Nuclear Medicine|August 2, 2024
Biodistribution and Radiation Dosimetry for 68 Ga-DOTA-CCK-66, a Novel CCK 2 R-Targeting Compound for Imaging of Medullary Thyroid CancerOliver Viering, Andreas Rinscheid, Nadine Holzleitner, et al.Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|July 6, 2022
[<sup>18</sup>F]FDG-PET/CT improves the detection of synchronous malignancies at primary staging of oral squamous cell carcinoma - A retrospective studyChristian Linz, Roman C Brands, Stephan Hackenberg, et al.Frontiers in Nuclear Medicine|October 2, 2024
Molecular Imaging in Multiple Myeloma-Novel PET Radiotracers Improve Patient Management and Guide TherapyJohannes von Hinten, Malte Kircher, Alexander Dierks, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 25, 2025
Biodistribution and Radiation Dosimetry of [<sup>68</sup>Ga]Ga-RAYZ-8009, a Glypican 3-Targeting Compound for Imaging of Hepatocellular CarcinomaOliver Viering, Julia Brosch-Lenz, Ralph A Bundschuh, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 2, 2024
First Safety and Efficacy Data with the Radiohybrid <sup>177</sup>Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate CancerAlexander Dierks, Alexander Gäble, Andreas Rinscheid, et al.International Journal of Immunopathology and Pharmacology|December 23, 2020
Sequential CD38 monoclonal antibody retreatment leads to deep remission in a patient with relapsed/refractory multiple myelomaMaximilian Johannes Steinhardt, Xiang Zhou, Franziska Krummenast, et al.Pageof 5